Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford, UK and benefits from excellent links with the global Ludwig Cancer Research and local Oxford research communities.
Ludwig Oxford Branch researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Our research groups are interested in the signalling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment. Find out more about the Ludwig Oxford research groups.
News
Vacancy: Senior Postdoctoral Scientist - Autoantibodies
26 March 2026
Publications
T-World Virtual Human Cardiomyocyte. I. Development, Validation, and Cell Arrhythmogenesis
Journal article
Tomek J. et al, (2026), Circulation Research
Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF
Journal article
Ma B. et al, (2026), Science Immunology, 11
Seminars
Targeting T cells to brain tumors
Thursday, 16 April 2026, 11am to 12pm
Speaker(s): Dr Michael Platten
Setting the Speed of DNA Replication: From Helicase Activation to Fork Rate Regulation
Thursday, 23 April 2026, 11am to 12pm
Speaker(s): Dr Joseph Yeeles (MRC Laboratory of Biology)
conference
